In clinical trials then the custom gene synthesis will be used in order to create the immunization. This will then be given to a test subject (often rats). From here a dose solution dried-blood spot assay can be performed on the subjects blood. Dose solution dried-blood spot assay can allow for the sample to be sent away. From here the ELISA biomarkers can be used in order to test for the presence of the created antigen, as well as the antibodies in order to test the effectiveness of the immunization and to therefore allow for changes to be made where necessary.
This then allows for the creation of immunizations that can help to protect us against a vast range of illnesses. While the same ELISA biomarkers can also be used in a range of other industries. This is just one form of bioanalysis – the process of testing for the amount of a substance in a sample – and there are many other tests that can be carried out to establish the presence and quantities of various other substances after clinical sample collection.
no comment untill now